查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1442616

首页 分子测试市场：按产品类型、最终用户、地区、规模、份额、成长、趋势、预测 2023-2030 年进行的全球产业分析

At-Home Molecular Testing Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2030
出版日期: | 出版商: Persistence Market Research | 英文 221 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research最近对家庭分子检测市场进行了深入分析，并提供了全球状况的综合报告。该报告提供了有关市场动态、趋势、机会和挑战的重要见解，并详细概述了市场结构。该研究报告预测了 2023 年至 2030 年家庭分子检测市场的预期成长轨迹，并提供了独特的数据和统计数据。

家庭分子检测市场预计将以 6.0% 的复合年增长率稳定成长。预计到 2030 年，这一数字将从 2023 年的 109 亿美元增加到 163 亿美元。

  • 重要见解

首页 分子检测市场规模（2023年）：美国：109亿美元

预测市场规模（2030F）：163亿美元

全球市场成长率（2023-2030年复合年增长率）：6.0%

过去的市场成长率（2018-2022年复合年增长率）：5.7%

首页 分子检测市场-调查范围

家庭分子检测市场正在迅速扩大，提供了个人可以在家中进行的便利分子诊断检测。这些测试通常分析遗传物质，例如 DNA 或 RNA，并提供对健康各个方面的深入瞭解，例如家庭关係、某些疾病的潜在风险和遗传倾向。这种创新的诊断方法使个人能够透过提供易于使用且方便的测试解决方案，采取积极主动的措施来管理自己的健康。持续的技术进步正在简化分子测试并降低成本，推动家庭分子测试市场的显着成长。

几个关键因素正在推动全球家庭分子检测产业的显着扩张。首先，人们对个人化医疗的认识和兴趣不断增强，推动了对基因检测服务的需求，这些服务可以对个人健康状况进行量身定制的分析。消费者越来越多地寻求遗传讯息，以便就预防措施、生活方式选择和潜在的医疗干预措施做出明智的决定。此外，分子生物学方法的进步和易于使用的测试工具的可用性简化了家庭分析所需的样本收集和提交过程。这种增加的便利性吸引了更广泛的用户群，并在市场成长中发挥至关重要的作用。

  • 市场成长动力

对个人化医疗不断增长的需求是全球家庭分子检测市场扩张的主要动力。这种形式的测试在个人化医疗保健的发展中发挥着重要作用，个人化医疗保健正在转向根据个人的基因谱量身定制医疗干预措施。个人化医疗的核心是相信医疗保健应根据每个患者独特的基因组成进行客製化。随着人们对瞭解个人遗传倾向的潜在好处的认识不断增强，对家庭分子检测的需求也相应增加。推动这种需求的是对主动健康管理的渴望。

在当今的医疗保健环境中，患者寻求的不是被动治疗，而是主动管理健康的知识。个人化医疗之所以有吸引力，是因为它可以识别个体对某些疾病的易感性，并允许人们根据遗传倾向采取预防措施或调整生活习惯。家庭分子检测透过为个人提供一种方便且易于使用的方法来分析其基因组成而无需访问临床机构，从而促进了这种主动方法。基因研究的进步发现了许多与多种健康状况相关的遗传标记，包括遗传疾病和与生活方式相关的疾病倾向。

  • 市场限制因素

全球家庭分子检测市场面临的关键挑战之一是确保在临床环境之外获得的结果的准确性和可靠性。家庭测试因其易于使用且易于使用而广受欢迎，但样本收集过程中缺乏专业监督引发了人们对潜在不准确和不一致的担忧。与传统实验室环境（由训练有素的专业人员监督样本采集）不同，DIY 测试会带来无意变化的风险，从而影响结果的准确性。在根据这些结果做出诊断和健康相关决策时，这一点尤其重要。适应监管环境并遵守严格的监管要求以确保检测服务的品质和可靠性已成为全球家庭分子检测市场的关键挑战。

随着家庭分子检测变得越来越普遍，监管机构面临着跟上技术进步的步伐同时保护消费者利益的复杂挑战。从健康倾向评估到谱系分析等各种可用的测试使监管环境变得更加复杂。平衡促进创新和消费者保护需要采取细緻的方法。我们面临的挑战是制定全面的法规，有效管理家庭检测，解决其独特的特征，确保结果的准确性，保护资料隐私，并最大限度地减少潜在的健康风险。这是为了抑制它。

  • 机会

机器学习（ML）和人工智慧（AI）技术的快速融合正在推动全球家庭分子检测市场向前发展。将先进的计算工具融入分子诊断有可能彻底改变家庭测试，提供提高效率、准确性和个人化见解的机会。随着家庭分子测试产生的遗传数据量的增加，机器学习和人工智慧演算法将在发现重要模式和相关性以及将原始数据转化为可行的见解方面发挥关键作用。

人工智慧和机器学习的融合将彻底改变遗传数据分析，使人们能够更全面地瞭解个人的健康状况。这些技术可以检测传统分析方法遗漏的微妙模式和关係，并且可以以超出人类能力的速度和规模分析海量资料集。这不仅提高了诊断结果的准确性，也为更先进和个人化的健康建议铺平了道路。人工智慧驱动的平台可以揭示复杂的遗传交互作用，并提供对疾病风险和潜在治疗反应的更深入见解。

本报告解决的关键问题

  • 目前全球家庭分子检测市场的规模和成长率是多少？
  • 推动家庭分子检测扩展的关键因素是什么？
  • 个人化医疗将如何促进这个市场的成长？
  • 家庭测试结果的准确性和可靠性有哪些挑战？
  • 哪些监管障碍和监管要求会影响家庭分子检测市场？

目录

第一章执行摘要

第二章市场概况

  • 市场范围和定义
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
    • 任务
    • 主要趋势
  • 产品生命週期分析
  • 首页 分子检测市场：价值链
    • 原材料供应商名单
    • 製造商名单
    • 经销商名单
    • 应用清单
    • 获利能力分析
  • 波特五力分析
  • 地缘政治紧张局势：对市场的影响
  • 宏观经济因素
    • 世界产业展望
    • 世界GDP成长率展望
    • 全球母公司市场概览
  • 预测变量 - 相关性和影响
  • 监管和技术格局

第三章 全球家庭分子检测市场展望：过去（2018-2022）与预测（2023-2030）

  • 主要亮点
    • 市场容量（单位）预测
    • 市场规模及年成长率
    • 绝对的赚钱机会
  • 市场规模（百万美元）分析与预测
    • 过去的市场规模分析，2013-2016
    • 目前市场规模预测，2018-2026
  • 全球家庭分子检测市场展望：产品
    • 简介/主要发现
    • 2018-2022 年依产品历史市场规模（百万美元）及销售量（单位）分析
    • 2023-2030 年按产品划分的当前市场规模（百万美元）和销售量（单位）预测
      • 卡式磁带
      • 条
      • 测试板
      • 浸卡
      • 中产阶级
      • 其他
  • 市场吸引力分析：产品
  • 全球家庭分子检测市场前景：检测类型
    • 简介/主要发现
    • 2018年至2022年按测试类型划分的历史市场规模（百万美元）和数量（单位）分析
    • 2023-2030 年按测试类型划分的当前市场规模（百万美元）和销售量（单位）预测
      • 怀孕测试
      • 艾滋病毒检测
      • 糖尿病
      • 感染
      • 葡萄糖测试
      • 排卵预测测试药
      • 药物滥用测试
      • 其他
  • 市场吸引力分析：测试型
  • 全球家庭分子检测市场展望：样本类型
    • 简介/主要发现
    • 2018年至2022年历史市场规模（百万美元）和数量（单位）分析（按样本类型）
    • 2023-2030 年按样本类型划分的当前市场规模（百万美元）和预测数量（单位）
      • 尿
      • 血液
      • 唾液
      • 其他
  • 市场吸引力分析：样本类型
  • 全球家庭分子检测市场前景：分销管道
    • 简介/主要发现
    • 2018-2022 年按分销管道划分的历史市场规模（百万美元）和销售（单位）分析
    • 2023-2030 年按分销管道划分的当前市场规模（百万美元）和预测数量（单位）
      • 零售药店
      • 药店
      • 超市/大卖场
      • 网上药店
  • 市场吸引力分析：分销管道

第四章全球家庭分子检测市场展望：地区

  • 主要亮点
  • 2018-2022 年按地区历史市场规模（百万美元）及成交量（单位）分析
  • 2023-2030 年按地区划分的当前市场规模（百万美元）和预测数量（单位）
    • 北美
    • 欧洲
    • 东亚
    • 南亚和大洋洲
    • 拉丁美洲
    • 中东和非洲 (MEA)
  • 市场吸引力分析：区域

第五章北美家庭分子检测市场展望：过去（2018-2022）与预测（2023-2030）

  • 主要亮点
  • 价格分析
  • 2018-2022 年历史市场规模（百万美元）与市场销售（单位）分析
  • 2023-2030 年各国目前市场规模（百万美元）及销售量（单位）预测
    • 美国
    • 加拿大
  • 2023-2030 年按产品划分的当前市场规模（百万美元）和销售量（单位）预测
  • 2023-2030 年按测试类型划分的当前市场规模（百万美元）和销售量（单位）预测
  • 2023-2030 年按样本类型划分的当前市场规模（百万美元）和预测数量（单位）
  • 2023-2030 年按分销管道划分的当前市场规模（百万美元）和预测数量（单位）
  • 市场吸引力分析

第六章欧洲家庭分子检测市场展望：过去（2018-2022）与预测（2023-2030）

  • 主要亮点
  • 价格分析
  • 2018-2022 年按市场划分的过往市场规模（百万美元）和销售量（单位）分析
    • 按国家
    • 按产品
    • 按测试类型
    • 依样品类型
    • 按分销渠道
  • 2023-2030 年各国目前市场规模（百万美元）及销售量（单位）预测
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 土耳其
    • 欧洲其他地区
  • 2023-2030 年按产品划分的当前市场规模（百万美元）和销售量（单位）预测
  • 2023-2030 年按测试类型划分的当前市场规模（百万美元）和销售量（单位）预测
  • 2023-2030 年按样本类型划分的当前市场规模（百万美元）和预测数量（单位）
  • 2023-2030 年按分销管道划分的当前市场规模（百万美元）和预测数量（单位）
  • 市场吸引力分析

第七章东亚家庭分子检测市场展望：过去（2018-2022）与预测（2023-2030）

  • 主要亮点
  • 价格分析
  • 2018-2022 年按市场划分的过往市场规模（百万美元）和销售量（单位）分析
    • 按国家
    • 按产品
    • 按测试类型
    • 依样品类型
    • 按分销渠道
  • 2023-2030 年各国目前市场规模（百万美元）及销售量（单位）预测
    • 中国
    • 日本
    • 韩国
  • 2023-2030 年按产品划分的当前市场规模（百万美元）和销售量（单位）预测
  • 按测试类型预测的当前市场规模（百万美元）和数量（单位）
  • 2023-2030 年按样本类型划分的当前市场规模（百万美元）和预测数量（单位）
  • 2023-2030 年按分销管道划分的当前市场规模（百万美元）和预测数量（单位）
  • 市场吸引力分析

第八章南亚和大洋洲首页分子检测市场展望：过去（2018-2022）和预测（2023-2030）

  • 主要亮点
  • 价格分析
  • 2018-2022 年按市场划分的过往市场规模（百万美元）和销售量（单位）分析
    • 按国家
    • 按产品
    • 按测试类型
    • 依样品类型
    • 按分销渠道
  • 2023-2030 年各国目前市场规模（百万美元）及销售量（单位）预测
    • 印度
    • 东南亚
    • 纽西兰
    • 南亚和大洋洲其他地区
  • 2023-2030 年按产品划分的当前市场规模（百万美元）和销售量（单位）预测
  • 2023-2030 年按测试类型划分的当前市场规模（百万美元）和销售量（单位）预测
  • 2023-2030 年按样本类型划分的当前市场规模（百万美元）和预测数量（单位）
  • 2023-2030 年按分销管道划分的当前市场规模（百万美元）和预测数量（单位）
  • 市场吸引力分析

第九章拉丁美洲家庭分子检测市场展望：过去（2018-2022）与预测（2023-2030）

  • 主要亮点
  • 价格分析
  • 2018-2022 年按市场划分的过往市场规模（百万美元）和销售量（单位）分析
    • 按国家
    • 按产品
    • 按测试类型
    • 依样品类型
    • 按分销渠道
  • 2023-2030 年各国目前市场规模（百万美元）及销售量（单位）预测
    • 巴西
    • 墨西哥
    • 其他拉丁美洲
  • 2023-2030 年按产品划分的当前市场规模（百万美元）和销售量（单位）预测
  • 2023-2030 年按测试类型划分的当前市场规模（百万美元）和销售量（单位）预测
  • 2023-2030 年按样本类型划分的当前市场规模（百万美元）和预测数量（单位）
  • 2023-2030 年按分销管道划分的当前市场规模（百万美元）和预测数量（单位）
  • 市场吸引力分析

第10章中东和非洲首页分子检测市场展望：过去（2018-2022）和预测（2023-2030）

  • 主要亮点
  • 价格分析
  • 2018-2022 年按市场划分的过往市场规模（百万美元）和销售量（单位）分析
    • 按国家
    • 按产品
    • 按测试类型
    • 依样品类型
    • 按分销渠道
  • 2023-2030 年各国目前市场规模（百万美元）及销售量（单位）预测
    • 海湾合作委员会
    • 埃及
    • 南非
    • 北非
    • 其他中东和非洲
  • 2023-2030 年按产品划分的当前市场规模（百万美元）和销售量（单位）预测
  • 2023-2030 年按测试类型划分的当前市场规模（百万美元）和销售量（单位）预测
  • 2023-2030 年按样本类型划分的当前市场规模（百万美元）和预测数量（单位）
  • 2023-2030 年按分销管道划分的当前市场规模（百万美元）和销售（单位）预测
  • 市场吸引力分析

第十一章竞争格局

  • 2022 年市场份额分析
  • 市场结构
    • 按市场划分的竞争强度图
    • 比赛仪表板
    • 表观产品容量
  • 公司简介（详细资讯 - 概述、财务、策略、近期发展）
    • Abbott
    • ACON Laboratories, Inc.
    • Rapikit
    • Becton and Dickinson
    • Cardinal Health
    • B. Braun Melsungen AG
    • Piramal Enterprises Ltd.
    • Siemens Healthcare GmbH
    • Quidel Corporation
    • Bionime Corporation
    • SA Scientific
    • ARKRAY USA, Inc.
    • Nova Biomedical
    • AdvaCare Pharma
    • AccuBioTech Co., Ltd.
    • Atlas Medical UK
    • TaiDoc Technology Corporation
    • Dragerwerk AG & Co. KGaA
    • F. Hoffmann-La Roche Ltd
    • Sensing Self
    • PTE. Ltd
    • Atomo Diagnostics
    • Mankind Pharma

第十二章附录

  • 调查方法
  • 调查假设
  • 缩写
简介目录
Product Code: PMRREP33685

Persistence Market Research has recently conducted an in-depth analysis of the At-Home Molecular Testing Market, providing a comprehensive report on the global landscape. This report offers key insights into market dynamics, trends, opportunities, and challenges, offering a detailed overview of the market structure. The research publication presents exclusive data and statistics, projecting the anticipated growth trajectory of the At-Home Molecular Testing Market from 2023 to 2030.

The at-home molecular testing market is projected to grow steadily, with a compound annual growth rate (CAGR) of 6.0%. It is expected to rise from its 2023 value of US$10.9 billion to reach US$16.3 billion by the conclusion of 2030.

  • Key Insights:

At-home Molecular Testing Market Size (2023E): US$10.9 Bn

Projected Market Value (2030F): US$16.3 Bn

Global Market Growth Rate (CAGR 2023 to 2030): 6.0%

Historical Market Growth Rate (CAGR 2018 to 2022): 5.7%

At-Home Molecular Testing Market - Report Scope

The at-home molecular testing market is witnessing rapid expansion, offering convenient molecular diagnostic tests that individuals can perform from their homes. These tests typically involve analyzing genetic material like DNA or RNA, providing insights into various aspects of health such as familial relationships, potential risks for specific diseases, and genetic predispositions. This innovative approach to diagnostics empowers individuals to take proactive steps towards managing their health by offering accessible and convenient testing solutions. With continuous technological advancements streamlining and reducing the cost of molecular testing, the at-home molecular testing market is experiencing significant growth.

Several key factors are driving the substantial expansion of the global at-home molecular testing industry. Firstly, the increasing recognition and interest in personalized medicine have fueled demand for genetic testing services, which offer tailored analyses of individual health profiles. Consumers are increasingly seeking genetic information to make well-informed decisions about preventive measures, lifestyle choices, and potential medical interventions. Additionally, advancements in molecular biology techniques and the availability of user-friendly testing tools have simplified the process of sample collection and submission for home-based analysis. This enhanced convenience has played a pivotal role in market growth, appealing to a broader range of user demographics.

  • Market Growth Drivers

The escalating demand for personalized medication is a significant driving force behind the global market expansion of at-home molecular testing. This form of testing plays a crucial role in the evolving landscape of personalized healthcare, which has shifted towards tailoring medical interventions based on individual genetic profiles. Central to personalized medicine is the belief that healthcare should be customized to each patient's unique genetic makeup. As awareness grows about the potential benefits of understanding one's genetic predispositions, there's been a corresponding increase in the demand for at-home molecular testing. This demand is fueled by a desire for proactive health management.

In today's healthcare environment, patients seek more than reactive treatments; they want to be empowered with knowledge to proactively manage their health. Personalized medicine holds appeal because it identifies individual susceptibilities to specific diseases, empowering people to adopt preventive measures and make lifestyle adjustments based on their genetic predispositions. At-home molecular testing facilitates this proactive approach by providing individuals with a convenient and accessible means to analyze their genetic composition without needing to visit a clinical facility. Advancements in genetic research have led to the discovery of numerous genetic markers associated with a wide range of health conditions, including hereditary diseases and predispositions to lifestyle-related ailments.

  • Market Restraints

One significant challenge facing the global market for at-home molecular testing is ensuring the precision and reliability of outcomes obtained outside of clinical settings. While the accessibility and user-friendliness of at-home testing have led to its widespread adoption, the absence of expert supervision during sample collection raises concerns about potential inaccuracies and inconsistencies. Unlike traditional laboratory settings where trained professionals oversee sample collection, DIY testing introduces the risk of inadvertent variables that may compromise result accuracy. This becomes particularly critical when making diagnostic and health-related decisions based on these outcomes. To ensure the quality and reliability of testing services, navigating the regulatory landscape and adhering to stringent oversight requirements pose significant challenges for the global at-home molecular testing market.

The growing prevalence of at-home molecular testing presents regulatory bodies with the complex task of keeping pace with technological advancements while safeguarding consumer interests. The regulatory environment is further complicated by the diverse range of tests available, spanning health predisposition assessments to ancestry profiling. Striking a balance between fostering innovation and protecting consumers necessitates a nuanced approach. The challenge lies in developing comprehensive regulations that effectively govern at-home testing, addressing its unique characteristics, ensuring result accuracy, safeguarding data privacy, and minimizing potential health risks.

  • Opportunities

The rapid integration of machine learning (ML) and Artificial Intelligence (AI) technologies is propelling the global market for at-home molecular testing forward. This incorporation of advanced computational tools with molecular diagnostics holds the potential to revolutionize at-home testing, offering opportunities for enhanced efficiency, precision, and personalized insights. As the volume of genetic data generated through at-home molecular testing increases, ML and AI algorithms play a crucial role in uncovering significant patterns and correlations, transforming raw data into actionable insights.

The fusion of AI and machine learning brings about a fundamental shift in genetic data analysis, allowing for more comprehensive understanding of an individual's health profile. These technologies can detect subtle patterns and associations that traditional analytical methods may overlook, analyzing vast datasets at speeds and scales beyond human capacity. This not only enhances the accuracy of diagnostic results but also opens avenues for more advanced and personalized health recommendations. AI-powered platforms can unravel intricate genetic interactions, offering deeper insights into disease risks and potential treatment responses.

Key Questions Answered in Report::

  • What is the current size and growth rate of the global at-home molecular testing market?
  • What are the main factors driving the expansion of at-home molecular testing?
  • How does personalized medicine contribute to the growth of this market?
  • What challenges exist regarding the precision and reliability of at-home testing outcomes?
  • What regulatory hurdles and oversight requirements impact the at-home molecular testing market?

Competitive Intelligence and Business Strategy

Prominent players in the at-home molecular testing market, such as 23andMe, MyHeritage, and AncestryDNA, bolster and expand their market dominance through strategic initiatives. One crucial strategy involves diversifying testing services to meet a wide range of consumer needs. These companies offer comprehensive genetic testing products encompassing health-related insights, carrier status for specific conditions, disease susceptibilities, and ancestry research. By providing such a broad range of services, they not only attract a larger customer base but also foster customer loyalty by continually providing valuable insights. Moreover, robust branding and marketing strategies are vital for establishing and maintaining market leadership. These companies invest significantly in advertising campaigns to educate consumers about the benefits of at-home molecular testing. To make genetic testing more accessible to the general public, persuasive messaging often relies on celebrity endorsements, customer testimonials, and compelling narratives. Furthermore, strategic partnerships with pharmaceutical firms, healthcare providers, and research institutions are integral to their approach. By forming such alliances, these companies integrate their at-home molecular testing solutions into broader healthcare networks, potentially influencing medical interventions and treatment strategies informed by genetic information. This integration positions them as key players at the intersection of mainstream healthcare and genetic testing, while also expanding their market presence.

  • Key Companies Profiled
  • Abbott
  • ACON Laboratories, Inc.
  • Rapikit
  • Becton and Dickinson
  • Cardinal Health
  • B. Braun Melsungen AG
  • Piramal Enterprises Ltd.
  • Siemens Healthcare GmbH
  • Quidel Corporation
  • Bionime Corporation
  • SA Scientific
  • ARKRAY USA, Inc.
  • Nova Biomedical
  • AdvaCare Pharma
  • AccuBioTech Co., Ltd.
  • Atlas Medical UK

TaiDoc Technology Corporation

  • Dragerwerk AG & Co. KGaA
  • F. Hoffmann-La Roche Ltd
  • Sensing Self
  • PTE. Ltd
  • Atomo Diagnostics
  • Mankind Pharma

At-home Molecular Testing Market Segmentation

  • By Product:
  • Cassettes
  • Strips
  • Test Panels
  • Dip Cards
  • Midstream
  • Others
  • By Test Type:
  • Pregnancy Tests
  • HIV Tests
  • Diabetes
  • Infectious Diseases
  • Glucose Tests
  • Ovulation Predictor Tests
  • Drug Abuse Tests
  • Others
  • By Sample Type:
  • Urine
  • Blood
  • Saliva
  • Others
  • By Distribution Channel:
  • Retail Pharmacies
  • Drug Stores
  • Supermarkets/Hypermarkets
  • Online Pharmacies
  • By Region:
  • North America
  • Europe
  • East Asia
  • South Asia & Oceania
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global At-home Molecular Testing Market Snapshot, 2023 and 2030
  • 1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Product Lifecycle Analysis
  • 2.4. At-home Molecular Testing Market: Value Chain
    • 2.4.1. List of Raw Material Supplier
    • 2.4.2. List of Manufacturers
    • 2.4.3. List of Distributors
    • 2.4.4. List of Applications
    • 2.4.5. Profitability Analysis
  • 2.5. Porter Five Force's Analysis
  • 2.6. Geopolitical Tensions: Market Impact
  • 2.7. Macro-Economic Factors
    • 2.7.1. Global Sectorial Outlook
    • 2.7.2. Global GDP Growth Outlook
    • 2.7.3. Global Parent Market Overview
  • 2.8. Forecast Factors - Relevance and Impact
  • 2.9. Regulatory and Technology Landscape

3. Global At-home Molecular Testing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 3.1. Key Highlights
    • 3.1.1. Market Volume (Units) Projections
    • 3.1.2. Market Size and Y-o-Y Growth
    • 3.1.3. Absolute $ Opportunity
  • 3.2. Market Size (US$ Mn) Analysis and Forecast
    • 3.2.1. Historical Market Size Analysis, 2013-2016
    • 3.2.2. Current Market Size Forecast, 2018-2026
  • 3.3. Global At-home Molecular Testing Market Outlook: Product
    • 3.3.1. Introduction / Key Findings
    • 3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product, 2018 - 2022
    • 3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
      • 3.3.3.1. Cassettes
      • 3.3.3.2. Strips
      • 3.3.3.3. Test Panels
      • 3.3.3.4. Dip Cards
      • 3.3.3.5. Midstreams
      • 3.3.3.6. Others
  • 3.4. Market Attractiveness Analysis: Product
  • 3.5. Global At-home Molecular Testing Market Outlook: Test Type
    • 3.5.1. Introduction / Key Findings
    • 3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Test Type, 2018 - 2022
    • 3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2023 - 2030
      • 3.5.3.1. Pregnancy Tests
      • 3.5.3.2. HIV Tests
      • 3.5.3.3. Diabetes
      • 3.5.3.4. Infectious Diseases
      • 3.5.3.5. Glucose Tests
      • 3.5.3.6. Ovulation Predictor Tests
      • 3.5.3.7. Drug Abuse Tests
      • 3.5.3.8. Others
  • 3.6. Market Attractiveness Analysis: Test Type
  • 3.7. Global At-home Molecular Testing Market Outlook: Sample Type
    • 3.7.1. Introduction / Key Findings
    • 3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Sample Type, 2018 - 2022
    • 3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Sample Type, 2023 - 2030
      • 3.7.3.1. Urine
      • 3.7.3.2. Blood
      • 3.7.3.3. Saliva
      • 3.7.3.4. Others
  • 3.8. Market Attractiveness Analysis: Sample Type
  • 3.9. Global At-home Molecular Testing Market Outlook: Distribution Channel
    • 3.9.1. Introduction / Key Findings
    • 3.9.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Distribution Channel, 2018 - 2022
    • 3.9.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
      • 3.9.3.1. Retail Pharmacies
      • 3.9.3.2. Drug Stores
      • 3.9.3.3. Supermarkets/Hypermarkets
      • 3.9.3.4. Online Pharmacies
  • 3.10. Market Attractiveness Analysis: Distribution Channel

4. Global At-home Molecular Testing Market Outlook: Region

  • 4.1. Key Highlights
  • 4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
  • 4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
    • 4.3.1. North America
    • 4.3.2. Europe
    • 4.3.3. East Asia
    • 4.3.4. South Asia and Oceania
    • 4.3.5. Latin America
    • 4.3.6. Middle East & Africa (MEA)
  • 4.4. Market Attractiveness Analysis: Region

5. North America At-home Molecular Testing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 5.1. Key Highlights
  • 5.2. Pricing Analysis
  • 5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 5.3.1. By Country
    • 5.3.2. By Product
    • 5.3.3. By Test Type
    • 5.3.4. By Sample Type
    • 5.3.5. By Distribution Channel
  • 5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 5.4.1. U.S.
    • 5.4.2. Canada
  • 5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
    • 5.5.1. Cassettes
    • 5.5.2. Strips
    • 5.5.3. Test Panels
    • 5.5.4. Dip Cards
    • 5.5.5. Midstreams
    • 5.5.6. Others
  • 5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2023 - 2030
    • 5.6.1. Pregnancy Tests
    • 5.6.2. HIV Tests
    • 5.6.3. Diabetes
    • 5.6.4. Infectious Diseases
    • 5.6.5. Glucose Tests
    • 5.6.6. Ovulation Predictor Tests
    • 5.6.7. Drug Abuse Tests
    • 5.6.8. Others
  • 5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Sample Type, 2023 - 2030
    • 5.7.1. Urine
    • 5.7.2. Blood
    • 5.7.3. Saliva
    • 5.7.4. Others
  • 5.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
    • 5.8.1. Retail Pharmacies
    • 5.8.2. Drug Stores
    • 5.8.3. Supermarkets/Hypermarkets
    • 5.8.4. Online Pharmacies
  • 5.9. Market Attractiveness Analysis

6. Europe At-home Molecular Testing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 6.1. Key Highlights
  • 6.2. Pricing Analysis
  • 6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 6.3.1. By Country
    • 6.3.2. By Product
    • 6.3.3. By Test Type
    • 6.3.4. By Sample Type
    • 6.3.5. By Distribution Channel
  • 6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 6.4.1. Germany
    • 6.4.2. France
    • 6.4.3. U.K.
    • 6.4.4. Italy
    • 6.4.5. Spain
    • 6.4.6. Russia
    • 6.4.7. Turkiye
    • 6.4.8. Rest of Europe
  • 6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
    • 6.5.1. Cassettes
    • 6.5.2. Strips
    • 6.5.3. Test Panels
    • 6.5.4. Dip Cards
    • 6.5.5. Midstreams
    • 6.5.6. Others
  • 6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2023 - 2030
    • 6.6.1. Pregnancy Tests
    • 6.6.2. HIV Tests
    • 6.6.3. Diabetes
    • 6.6.4. Infectious Diseases
    • 6.6.5. Glucose Tests
    • 6.6.6. Ovulation Predictor Tests
    • 6.6.7. Drug Abuse Tests
    • 6.6.8. Others
  • 6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Sample Type, 2023 - 2030
    • 6.7.1. Urine
    • 6.7.2. Blood
    • 6.7.3. Saliva
    • 6.7.4. Others
  • 6.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
    • 6.8.1. Retail Pharmacies
    • 6.8.2. Drug Stores
    • 6.8.3. Supermarkets/Hypermarkets
    • 6.8.4. Online Pharmacies
  • 6.9. Market Attractiveness Analysis

7. East Asia At-home Molecular Testing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 7.1. Key Highlights
  • 7.2. Pricing Analysis
  • 7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 7.3.1. By Country
    • 7.3.2. By Product
    • 7.3.3. By Test Type
    • 7.3.4. By Sample Type
    • 7.3.5. By Distribution Channel
  • 7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 7.4.1. China
    • 7.4.2. Japan
    • 7.4.3. South Korea
  • 7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
    • 7.5.1. Cassettes
    • 7.5.2. Strips
    • 7.5.3. Test Panels
    • 7.5.4. Dip Cards
    • 7.5.5. Midstreams
    • 7.5.6. Others
  • 7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2023 - 2030
    • 7.6.1. Pregnancy Tests
    • 7.6.2. HIV Tests
    • 7.6.3. Diabetes
    • 7.6.4. Infectious Diseases
    • 7.6.5. Glucose Tests
    • 7.6.6. Ovulation Predictor Tests
    • 7.6.7. Drug Abuse Tests
    • 7.6.8. Others
  • 7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Sample Type, 2023 - 2030
    • 7.7.1. Urine
    • 7.7.2. Blood
    • 7.7.3. Saliva
    • 7.7.4. Others
  • 7.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
    • 7.8.1. Retail Pharmacies
    • 7.8.2. Drug Stores
    • 7.8.3. Supermarkets/Hypermarkets
    • 7.8.4. Online Pharmacies
  • 7.9. Market Attractiveness Analysis

8. South Asia & Oceania At-home Molecular Testing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 8.1. Key Highlights
  • 8.2. Pricing Analysis
  • 8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 8.3.1. By Country
    • 8.3.2. By Product
    • 8.3.3. By Test Type
    • 8.3.4. By Sample Type
    • 8.3.5. By Distribution Channel
  • 8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 8.4.1. India
    • 8.4.2. Southeast Asia
    • 8.4.3. ANZ
    • 8.4.4. Rest of South Asia & Oceania
  • 8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
    • 8.5.1. Cassettes
    • 8.5.2. Strips
    • 8.5.3. Test Panels
    • 8.5.4. Dip Cards
    • 8.5.5. Midstreams
    • 8.5.6. Others
  • 8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2023 - 2030
    • 8.6.1. Pregnancy Tests
    • 8.6.2. HIV Tests
    • 8.6.3. Diabetes
    • 8.6.4. Infectious Diseases
    • 8.6.5. Glucose Tests
    • 8.6.6. Ovulation Predictor Tests
    • 8.6.7. Drug Abuse Tests
    • 8.6.8. Others
  • 8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Sample Type, 2023 - 2030
    • 8.7.1. Urine
    • 8.7.2. Blood
    • 8.7.3. Saliva
    • 8.7.4. Others
  • 8.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
    • 8.8.1. Retail Pharmacies
    • 8.8.2. Drug Stores
    • 8.8.3. Supermarkets/Hypermarkets
    • 8.8.4. Online Pharmacies
  • 8.9. Market Attractiveness Analysis

9. Latin America At-home Molecular Testing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 9.1. Key Highlights
  • 9.2. Pricing Analysis
  • 9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 9.3.1. By Country
    • 9.3.2. By Product
    • 9.3.3. By Test Type
    • 9.3.4. By Sample Type
    • 9.3.5. By Distribution Channel
  • 9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America
  • 9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
    • 9.5.1. Cassettes
    • 9.5.2. Strips
    • 9.5.3. Test Panels
    • 9.5.4. Dip Cards
    • 9.5.5. Midstreams
    • 9.5.6. Others
  • 9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2023 - 2030
    • 9.6.1. Pregnancy Tests
    • 9.6.2. HIV Tests
    • 9.6.3. Diabetes
    • 9.6.4. Infectious Diseases
    • 9.6.5. Glucose Tests
    • 9.6.6. Ovulation Predictor Tests
    • 9.6.7. Drug Abuse Tests
    • 9.6.8. Others
  • 9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Sample Type, 2023 - 2030
    • 9.7.1. Urine
    • 9.7.2. Blood
    • 9.7.3. Saliva
    • 9.7.4. Others
  • 9.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
    • 9.8.1. Retail Pharmacies
    • 9.8.2. Drug Stores
    • 9.8.3. Supermarkets/Hypermarkets
    • 9.8.4. Online Pharmacies
  • 9.9. Market Attractiveness Analysis

10. Middle East & Africa At-home Molecular Testing Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 10.1. Key Highlights
  • 10.2. Pricing Analysis
  • 10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 10.3.1. By Country
    • 10.3.2. By Product
    • 10.3.3. By Test Type
    • 10.3.4. By Sample Type
    • 10.3.5. By Distribution Channel
  • 10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 10.4.1. GCC
    • 10.4.2. Egypt
    • 10.4.3. South Africa
    • 10.4.4. Northern Africa
    • 10.4.5. Rest of Middle East & Africa
  • 10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
    • 10.5.1. Cassettes
    • 10.5.2. Strips
    • 10.5.3. Test Panels
    • 10.5.4. Dip Cards
    • 10.5.5. Midstreams
    • 10.5.6. Others
  • 10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Test Type, 2023 - 2030
    • 10.6.1. Pregnancy Tests
    • 10.6.2. HIV Tests
    • 10.6.3. Diabetes
    • 10.6.4. Infectious Diseases
    • 10.6.5. Glucose Tests
    • 10.6.6. Ovulation Predictor Tests
    • 10.6.7. Drug Abuse Tests
    • 10.6.8. Others
  • 10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Sample Type, 2023 - 2030
    • 10.7.1. Urine
    • 10.7.2. Blood
    • 10.7.3. Saliva
    • 10.7.4. Others
  • 10.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
    • 10.8.1. Retail Pharmacies
    • 10.8.2. Drug Stores
    • 10.8.3. Supermarkets/Hypermarkets
    • 10.8.4. Online Pharmacies
  • 10.9. Market Attractiveness Analysis

11. Competition Landscape

  • 11.1. Market Share Analysis, 2022
  • 11.2. Market Structure
    • 11.2.1. Competition Intensity Mapping By Market
    • 11.2.2. Competition Dashboard
    • 11.2.3. Apparent Product Capacity
  • 11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 11.3.1. Abbott
      • 11.3.1.1. Overview
      • 11.3.1.2. Segments and Product
      • 11.3.1.3. Key Financials
      • 11.3.1.4. Market Developments
      • 11.3.1.5. Market Strategy
    • 11.3.2. ACON Laboratories, Inc.
      • 11.3.2.1. Overview
      • 11.3.2.2. Segments and Product
      • 11.3.2.3. Key Financials
      • 11.3.2.4. Market Developments
      • 11.3.2.5. Market Strategy
    • 11.3.3. Rapikit
      • 11.3.3.1. Overview
      • 11.3.3.2. Segments and Product
      • 11.3.3.3. Key Financials
      • 11.3.3.4. Market Developments
      • 11.3.3.5. Market Strategy
    • 11.3.4. Becton and Dickinson
      • 11.3.4.1. Overview
      • 11.3.4.2. Segments and Product
      • 11.3.4.3. Key Financials
      • 11.3.4.4. Market Developments
      • 11.3.4.5. Market Strategy
    • 11.3.5. Cardinal Health
      • 11.3.5.1. Overview
      • 11.3.5.2. Segments and Product
      • 11.3.5.3. Key Financials
      • 11.3.5.4. Market Developments
      • 11.3.5.5. Market Strategy
    • 11.3.6. B. Braun Melsungen AG
      • 11.3.6.1. Overview
      • 11.3.6.2. Segments and Product
      • 11.3.6.3. Key Financials
      • 11.3.6.4. Market Developments
      • 11.3.6.5. Market Strategy
    • 11.3.7. Piramal Enterprises Ltd.
      • 11.3.7.1. Overview
      • 11.3.7.2. Segments and Product
      • 11.3.7.3. Key Financials
      • 11.3.7.4. Market Developments
      • 11.3.7.5. Market Strategy
    • 11.3.8. Siemens Healthcare GmbH
      • 11.3.8.1. Overview
      • 11.3.8.2. Segments and Product
      • 11.3.8.3. Key Financials
      • 11.3.8.4. Market Developments
      • 11.3.8.5. Market Strategy
    • 11.3.9. Quidel Corporation
      • 11.3.9.1. Overview
      • 11.3.9.2. Segments and Product
      • 11.3.9.3. Key Financials
      • 11.3.9.4. Market Developments
      • 11.3.9.5. Market Strategy
    • 11.3.10. Bionime Corporation
      • 11.3.10.1. Overview
      • 11.3.10.2. Segments and Product
      • 11.3.10.3. Key Financials
      • 11.3.10.4. Market Developments
      • 11.3.10.5. Market Strategy
    • 11.3.11. SA Scientific
      • 11.3.11.1. Overview
      • 11.3.11.2. Segments and Product
      • 11.3.11.3. Key Financials
      • 11.3.11.4. Market Developments
      • 11.3.11.5. Market Strategy
    • 11.3.12. ARKRAY USA, Inc.
      • 11.3.12.1. Overview
      • 11.3.12.2. Segments and Product
      • 11.3.12.3. Key Financials
      • 11.3.12.4. Market Developments
      • 11.3.12.5. Market Strategy
    • 11.3.13. Nova Biomedical
      • 11.3.13.1. Overview
      • 11.3.13.2. Segments and Product
      • 11.3.13.3. Key Financials
      • 11.3.13.4. Market Developments
      • 11.3.13.5. Market Strategy
    • 11.3.14. AdvaCare Pharma
      • 11.3.14.1. Overview
      • 11.3.14.2. Segments and Product
      • 11.3.14.3. Key Financials
      • 11.3.14.4. Market Developments
      • 11.3.14.5. Market Strategy
    • 11.3.15. AccuBioTech Co., Ltd.
      • 11.3.15.1. Overview
      • 11.3.15.2. Segments and Product
      • 11.3.15.3. Key Financials
      • 11.3.15.4. Market Developments
      • 11.3.15.5. Market Strategy
    • 11.3.16. Atlas Medical UK
      • 11.3.16.1. Overview
      • 11.3.16.2. Segments and Product
      • 11.3.16.3. Key Financials
      • 11.3.16.4. Market Developments
      • 11.3.16.5. Market Strategy
    • 11.3.17. TaiDoc Technology Corporation
      • 11.3.17.1. Overview
      • 11.3.17.2. Segments and Product
      • 11.3.17.3. Key Financials
      • 11.3.17.4. Market Developments
      • 11.3.17.5. Market Strategy
    • 11.3.18. Dragerwerk AG & Co. KGaA
      • 11.3.18.1. Overview
      • 11.3.18.2. Segments and Product
      • 11.3.18.3. Key Financials
      • 11.3.18.4. Market Developments
      • 11.3.18.5. Market Strategy
    • 11.3.19. F. Hoffmann-La Roche Ltd
      • 11.3.19.1. Overview
      • 11.3.19.2. Segments and Product
      • 11.3.19.3. Key Financials
      • 11.3.19.4. Market Developments
      • 11.3.19.5. Market Strategy
    • 11.3.20. Sensing Self
      • 11.3.20.1. Overview
      • 11.3.20.2. Segments and Product
      • 11.3.20.3. Key Financials
      • 11.3.20.4. Market Developments
      • 11.3.20.5. Market Strategy
    • 11.3.21. PTE. Ltd
      • 11.3.21.1. Overview
      • 11.3.21.2. Segments and Product
      • 11.3.21.3. Key Financials
      • 11.3.21.4. Market Developments
      • 11.3.21.5. Market Strategy
    • 11.3.22. Atomo Diagnostics
      • 11.3.22.1. Overview
      • 11.3.22.2. Segments and Product
      • 11.3.22.3. Key Financials
      • 11.3.22.4. Market Developments
      • 11.3.22.5. Market Strategy
    • 11.3.23. Mankind Pharma
      • 11.3.23.1. Overview
      • 11.3.23.2. Segments and Product
      • 11.3.23.3. Key Financials
      • 11.3.23.4. Market Developments
      • 11.3.23.5. Market Strategy

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Research Assumptions
  • 12.3. Acronyms and Abbreviations